AU2791002A - Novel medicament compositions based on tiotropium salts and on salmeterol salts - Google Patents
Novel medicament compositions based on tiotropium salts and on salmeterol saltsInfo
- Publication number
- AU2791002A AU2791002A AU2791002A AU2791002A AU2791002A AU 2791002 A AU2791002 A AU 2791002A AU 2791002 A AU2791002 A AU 2791002A AU 2791002 A AU2791002 A AU 2791002A AU 2791002 A AU2791002 A AU 2791002A
- Authority
- AU
- Australia
- Prior art keywords
- salts
- salmeterol
- tiotropium
- compositions based
- medicament compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Drug compositions containing one or more tiotropium salts and one or more salmeterol salts, are new. Drug compositions containing one or more tiotropium salts and one or more salmeterol salts, are new. The salts can be present in the form of enantiomers, enantiomer mixtures or racemates as well as in the form of solvates or hydrates. The compositions may also contain a pharmaceutical adjuvant. ACTIVITY : Antiasthmatic. MECHANISM OF ACTION : Anticholinergic; beta -mimetic.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10056104A DE10056104A1 (en) | 2000-11-13 | 2000-11-13 | Drug compositions useful for treatment of respiratory diseases, especially asthma and chronic obstructive pulmonary disease comprises tiotropium salts and salmeterol salts |
| PCT/EP2001/012962 WO2002038154A1 (en) | 2000-11-13 | 2001-11-09 | Novel medicament compositions based on tiotropium salts and on salmeterol salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2791002A true AU2791002A (en) | 2002-05-21 |
Family
ID=7663071
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2791002A Pending AU2791002A (en) | 2000-11-13 | 2001-11-09 | Novel medicament compositions based on tiotropium salts and on salmeterol salts |
| AU2002227910A Ceased AU2002227910B2 (en) | 2000-11-13 | 2001-11-09 | Novel medicament compositions based on tiotropium salts and on salmeterol salts |
| AU2007202303A Ceased AU2007202303B2 (en) | 2000-11-13 | 2007-05-22 | Novel medicament compositions based on tiotropium salts and on salmeterol salts |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002227910A Ceased AU2002227910B2 (en) | 2000-11-13 | 2001-11-09 | Novel medicament compositions based on tiotropium salts and on salmeterol salts |
| AU2007202303A Ceased AU2007202303B2 (en) | 2000-11-13 | 2007-05-22 | Novel medicament compositions based on tiotropium salts and on salmeterol salts |
Country Status (32)
| Country | Link |
|---|---|
| EP (3) | EP1808174A1 (en) |
| JP (2) | JP4282322B2 (en) |
| KR (2) | KR100886094B1 (en) |
| CN (1) | CN1678318A (en) |
| AT (2) | ATE362761T1 (en) |
| AU (3) | AU2791002A (en) |
| BG (1) | BG107781A (en) |
| BR (1) | BR0115226A (en) |
| CA (1) | CA2429012A1 (en) |
| CY (1) | CY1106774T1 (en) |
| CZ (1) | CZ20031444A3 (en) |
| DE (3) | DE10056104A1 (en) |
| DK (2) | DK1514546T3 (en) |
| EA (1) | EA007904B1 (en) |
| EC (1) | ECSP034571A (en) |
| EE (1) | EE200300228A (en) |
| ES (2) | ES2240549T3 (en) |
| HR (1) | HRP20030378A2 (en) |
| HU (1) | HUP0301447A3 (en) |
| IL (2) | IL155718A0 (en) |
| MX (1) | MXPA03004164A (en) |
| NO (1) | NO20032111L (en) |
| NZ (1) | NZ526400A (en) |
| PL (1) | PL205330B1 (en) |
| PT (2) | PT1514546E (en) |
| RS (2) | RS50286B (en) |
| SG (1) | SG167657A1 (en) |
| SI (2) | SI1514546T1 (en) |
| SK (2) | SK286950B6 (en) |
| UA (1) | UA74853C2 (en) |
| WO (1) | WO2002038154A1 (en) |
| ZA (1) | ZA200302921B (en) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (en) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
| US7214687B2 (en) | 1999-07-14 | 2007-05-08 | Almirall Ag | Quinuclidine derivatives and medicinal compositions containing the same |
| WO2001037805A1 (en) * | 1999-11-23 | 2001-05-31 | Glaxo Group Limited | Pharmaceutical formulations of salmeterol |
| CA2459493C (en) * | 2001-09-14 | 2011-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New pharmaceutical compositions for inhalation |
| DE10214263A1 (en) * | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA suspension formulations containing an anticholinergic |
| US7244415B2 (en) | 2002-03-28 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations of an anhydrate |
| US7311894B2 (en) | 2002-03-28 | 2007-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations containing an anticholinergic |
| DE10256080A1 (en) * | 2002-11-29 | 2004-06-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Combination medicinal product for inhalation containing tiotropium |
| US7250426B2 (en) | 2002-11-29 | 2007-07-31 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Tiotropium-containing pharmaceutical combination for inhalation |
| CA2510043A1 (en) * | 2002-12-16 | 2004-07-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing hfc solution formulations |
| DE10351663A1 (en) * | 2002-12-20 | 2004-07-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Stable, accurately dosable inhalable powder medicament for treating asthma or chronic obstructive pulmonary disease, containing tiotropium, specific form of salmeterol xinafoate and auxiliary |
| DE10345065A1 (en) * | 2003-09-26 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
| UY28589A1 (en) * | 2003-11-03 | 2005-06-30 | Boehringer Ingelheim Int | NEW TIOTROPE SALTS, PROCEDURES FOR PREPARATION, AS WELL AS MEDICINAL FORMULATIONS CONTAINING THEM |
| PT1682541E (en) | 2003-11-03 | 2010-04-14 | Boehringer Ingelheim Int | Method for producing tiotropium salts |
| DE602005018969D1 (en) * | 2004-05-31 | 2010-03-04 | Almirall Sa | Compositions with antimuscarinic agents and corticosteroids |
| ES2257152B1 (en) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS. |
| ES2393794T3 (en) | 2005-05-02 | 2012-12-28 | Boehringer Ingelheim International Gmbh | New crystalline forms of tiotropium bromide |
| CA2617897A1 (en) * | 2005-08-06 | 2007-02-15 | Boehringer Ingelheim International Gmbh | Method for the treatment of dyspnea comprising combined administration of tiotropium salts and salts of salmeterol |
| ES2298049B1 (en) | 2006-07-21 | 2009-10-20 | Laboratorios Almirall S.A. | PROCEDURE FOR MANUFACTURING BROMIDE OF 3 (R) - (2-HIDROXI-2,2-DITIEN-2-ILACETOXI) -1- (3-PHENOXIPROPIL) -1-AZONIABICICLO (2.2.2) OCTANO. |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| US20120220557A1 (en) * | 2011-02-17 | 2012-08-30 | Chiesi Farmaceutici S.P.A. | Liquid propellant-free formulation comprising an antimuscarinic drug |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| WO2013127738A1 (en) * | 2012-02-28 | 2013-09-06 | Boehringer Ingelheim International Gmbh | Novel propellant-gas-containing tiotropium formulation |
| WO2015065222A1 (en) * | 2013-10-28 | 2015-05-07 | Шолекс Девелопмент Гмбх | Pharmaceutical inhaled drug with micronized tiotropium bromide as active ingredient for the treatment of bronchial asthma and chronic obstructive pulmonary disease and method for producing same |
| TW201835041A (en) | 2017-02-17 | 2018-10-01 | 印度商托仁特生技有限公司 | Compounds with Beta-Adrenergic Agonist and Antimuscarinic Activity |
| WO2019142214A1 (en) * | 2018-01-19 | 2019-07-25 | Cipla Limited | Pharmaceutical composition comprising tiotropium for inhalation |
| WO2020019952A1 (en) * | 2018-07-26 | 2020-01-30 | 四川海思科制药有限公司 | Aerosol pharmaceutical composition containing glycopyrrolate salt and indacaterol salt, preparation method therefor, and uses thereof |
| CN116196298A (en) * | 2018-07-26 | 2023-06-02 | 四川海思科制药有限公司 | Aerosol pharmaceutical composition containing glycopyrronium salt and preparation method and application thereof |
| US11826382B2 (en) | 2020-05-01 | 2023-11-28 | Tygrus, LLC | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses |
| US11642372B2 (en) | 2020-05-01 | 2023-05-09 | Tygrus, LLC | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses |
| WO2022119661A1 (en) * | 2020-12-04 | 2022-06-09 | Tygrus, LLC | THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1100465B1 (en) * | 1998-07-24 | 2004-11-24 | Jago Research Ag | Medicinal aerosol formulations |
| DE19835346A1 (en) * | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Two-part capsule for pharmaceutical preparations for powder inhalers |
| DE19847971A1 (en) * | 1998-10-17 | 1999-09-02 | Schiering | Filter fire occurrence prevention method |
| DE19847970A1 (en) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Stable concentrated liquid formulation of inhalable drug, e.g. formoterol or salbutamol, in solution or suspension medium, used after dilution for treatment of respiratory disorders by inhalation |
| DE19921693A1 (en) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects |
| DE19961300A1 (en) * | 1999-12-18 | 2001-06-21 | Asta Medica Ag | Storage system for medicinal products in powder form and inhaler equipped with them |
-
2000
- 2000-11-13 DE DE10056104A patent/DE10056104A1/en not_active Withdrawn
-
2001
- 2001-09-11 UA UA2003065486A patent/UA74853C2/en unknown
- 2001-11-09 AU AU2791002A patent/AU2791002A/en active Pending
- 2001-11-09 SI SI200130751T patent/SI1514546T1/en unknown
- 2001-11-09 HU HU0301447A patent/HUP0301447A3/en unknown
- 2001-11-09 DK DK04028508T patent/DK1514546T3/en active
- 2001-11-09 AU AU2002227910A patent/AU2002227910B2/en not_active Ceased
- 2001-11-09 EP EP07104722A patent/EP1808174A1/en not_active Withdrawn
- 2001-11-09 DE DE50105729T patent/DE50105729D1/en not_active Expired - Lifetime
- 2001-11-09 RS YUP-355/03A patent/RS50286B/en unknown
- 2001-11-09 PT PT04028508T patent/PT1514546E/en unknown
- 2001-11-09 AT AT04028508T patent/ATE362761T1/en active
- 2001-11-09 AT AT01989446T patent/ATE291428T1/en active
- 2001-11-09 PT PT01989446T patent/PT1335728E/en unknown
- 2001-11-09 EP EP04028508A patent/EP1514546B1/en not_active Expired - Lifetime
- 2001-11-09 MX MXPA03004164A patent/MXPA03004164A/en active IP Right Grant
- 2001-11-09 DK DK01989446T patent/DK1335728T3/en active
- 2001-11-09 WO PCT/EP2001/012962 patent/WO2002038154A1/en active Application Filing
- 2001-11-09 PL PL365989A patent/PL205330B1/en not_active IP Right Cessation
- 2001-11-09 IL IL15571801A patent/IL155718A0/en unknown
- 2001-11-09 NZ NZ526400A patent/NZ526400A/en unknown
- 2001-11-09 EA EA200300503A patent/EA007904B1/en not_active IP Right Cessation
- 2001-11-09 SI SI200130347T patent/SI1335728T1/en unknown
- 2001-11-09 CA CA002429012A patent/CA2429012A1/en not_active Abandoned
- 2001-11-09 EP EP01989446A patent/EP1335728B1/en not_active Expired - Lifetime
- 2001-11-09 SK SK50015-2009A patent/SK286950B6/en not_active IP Right Cessation
- 2001-11-09 CN CNA018187773A patent/CN1678318A/en active Pending
- 2001-11-09 KR KR1020037006434A patent/KR100886094B1/en not_active IP Right Cessation
- 2001-11-09 SG SG200505149-5A patent/SG167657A1/en unknown
- 2001-11-09 ES ES01989446T patent/ES2240549T3/en not_active Expired - Lifetime
- 2001-11-09 KR KR1020087020177A patent/KR100940752B1/en not_active IP Right Cessation
- 2001-11-09 BR BR0115226-2A patent/BR0115226A/en active Pending
- 2001-11-09 SK SK741-2003A patent/SK286939B6/en not_active IP Right Cessation
- 2001-11-09 ES ES04028508T patent/ES2287629T3/en not_active Expired - Lifetime
- 2001-11-09 EE EEP200300228A patent/EE200300228A/en unknown
- 2001-11-09 RS RSP-2009/0105A patent/RS20090105A/en unknown
- 2001-11-09 DE DE50112535T patent/DE50112535D1/en not_active Expired - Lifetime
- 2001-11-09 JP JP2002540737A patent/JP4282322B2/en not_active Expired - Lifetime
- 2001-11-09 CZ CZ20031444A patent/CZ20031444A3/en unknown
-
2003
- 2003-04-14 ZA ZA200302921A patent/ZA200302921B/en unknown
- 2003-04-28 EC EC2003004571A patent/ECSP034571A/en unknown
- 2003-05-01 IL IL155718A patent/IL155718A/en not_active IP Right Cessation
- 2003-05-08 BG BG107781A patent/BG107781A/en active Pending
- 2003-05-12 HR HR20030378A patent/HRP20030378A2/en not_active Application Discontinuation
- 2003-05-12 NO NO20032111A patent/NO20032111L/en not_active Application Discontinuation
-
2004
- 2004-12-08 JP JP2004355226A patent/JP4282594B2/en not_active Expired - Lifetime
-
2007
- 2007-05-22 AU AU2007202303A patent/AU2007202303B2/en not_active Ceased
- 2007-07-30 CY CY20071101011T patent/CY1106774T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL155718A0 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
| MY129512A (en) | Novel medicament compositions, based on tiotropium bromide and salmeterol | |
| PL355331A1 (en) | Novel composition and use | |
| IL151202A0 (en) | Phenyl derivatives, a process for their praparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy | |
| AU2002227910A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
| WO2004055006A8 (en) | Novel compounds having selective inhibiting effect at gsk3 | |
| WO2002036135A3 (en) | Compositions for antitumour treatment containing ecteinascidin 743 | |
| TW200606147A (en) | Indolyl derivatives as liver-X-receptor modulators | |
| WO2000058293A3 (en) | Glucokinase activators | |
| RS50218B (en) | Crystalline monohydrate,method for producing the same and the use thereof in the production of a medicament | |
| HK1046374A1 (en) | Camptothecin analogs and methods of preparation thereof | |
| RS99804A (en) | Novel compounds and their use | |
| MY134167A (en) | Biphenylcarboxamides useful as lipid lowering agents | |
| HK1045113A1 (en) | Oral administration form for administering a fixed tramadol and diclofenac combination | |
| NZ516290A (en) | Substituted phenoxyacetic acids | |
| HUP0204360A3 (en) | Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament and medicaments containing said compounds | |
| TW200517146A (en) | Novel composition | |
| SI1572622T1 (en) | use of levalbuterol L-tartrate in the production of a metered dose inhaler | |
| SE0000303D0 (en) | Novel compounds | |
| PE20020525A1 (en) | COMPOSITIONS INCLUDING TIOTROPE SALTS AND ANTIHISTAMINE AGENTS | |
| MY141724A (en) | Medicaments containing betamimetic drugs and a novel anticholinesterase drug | |
| ATE306940T1 (en) | COMPOSITION AGAINST COCCIDIOSIS | |
| DK1370529T3 (en) | Substituted dimethyl - [- 1 (1-phenyl-cyclohexyl) -piperidin-3-ylmethyl] -amines and use as analgesics | |
| WO2001053322A3 (en) | Aerothricin analogs, their preparation and use |